Validation of thrombotic risk factors in 1381 patients with essential thrombocythaemia: A multicentre retrospective real‐life study-Reference-Cited by-同舟云学术

Validation of thrombotic risk factors in 1381 patients with essential thrombocythaemia: A multicentre retrospective real‐life study

Published:2022-07-29 Issue:1 Volume:199 Page:86-94
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Stuckey Ruth¹^ORCID,Ianotto Jean‐Christophe²,Santoro Marco³,Czyż Anna⁴^ORCID,Perez Encinas Manuel M.⁵,Gómez‐Casares María Teresa¹,Noya Pereira Maria Soledad⁶,de Nałęcz Anna Kulikowska⁷,Gołos Aleksandra⁸,Lewandowski Krzysztof⁹,Szukalski Łukasz¹⁰,González‐Martín Jesús M.¹¹,Wróbel Tomasz⁴,Sobas Marta Anna⁴^ORCID

Affiliation:

1. Hematology Department Hospital Universitario de Gran Canaria Dr. Negrín Las Palmas Spain

2. Service d'Hématologie Clinique, Institut de Cancéro‐Hématologie Centre Hospitalier Régional et Universitaire de Brest Brest France

3. Hematology Unit, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE) University of Palermo Palermo Italy

4. Department of Hematology and Bone Marrow Transplantation Wroclaw Medical University Wroclaw Poland

5. Hematology Department Hospital Clínico Universitario de Santiago de Compostela Santiago de Compostela Spain

6. Hematology Department Hospital Clínico Universitario de A Coruña A Coruña Spain

7. Department of Hematology, Oncology and Internal Medicine Szpital Wojewódzki Opole Poland

8. Department of Hematology Institute of Hematology Warsaw Poland

9. Department of Hematology and Bone Marrow Transplantation Poznan University of Medical Sciences Poznan Poland

10. Department of Haematology CM UMK in Bydgoszcz Nicolaus Copernicus University in Toruń Toruń Poland

11. Investigation Unit Hospital Universitario de Gran Canaria Dr. Negrín Las Palmas Spain

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18387

Reference31 articles.

1. Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

2. Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria

3. Hemorrhagic Complications Associated With Aspirin

4. Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aberrant Platelet Aggregation as Initial Presentation of Essential Thrombocythemia: Failure of Entero-Coated Aspirin to Reduce Platelet Hyperactivation;International Journal of Molecular Sciences;2023-12-22

2. Prediction of major bleeding events in 1381 patients with essential thrombocythemia;International Journal of Hematology;2023-09-03

3. Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia;HemaSphere;2023-07-18

4. The atherogenic index of plasma complicates the thrombotic tendency of chronic myeloproliferative disorders: A retrospective cohort study;DAHUDER Medical Journal;2023-04-29

5. Aspirin in essential thrombocythemia. For whom? What formulation? What regimen?;Haematologica;2023-01-12